Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06136520
Other study ID # 2023/132
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 26, 2023
Est. completion date March 1, 2024

Study information

Verified date April 2024
Source Istanbul University - Cerrahpasa (IUC)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The research to be conducted within the scope of the project will be randomized controlled, and the population of the research will be primiparous pregnant women reached through social media. Primiparous pregnant women in the 32nd - 40th weeks of pregnancy will be included in the study, and the sample size is determined by using the G*Power (3.1.9.2) program, considering a margin of error of 0.05 and data loss, with a power of 95% and a medium effect size; 27 people should be included in the experimental (baby massage) group and 27 people in the control group. In determining the groups, participants will be assigned to experimental and control groups using the "Randomizer.org" program. Pregnant women included in the research will be informed about the study and will be presented with an "Informed Consent Form" and "Voluntary Consent Form". Baby massage training will be given to the experimental group, and a reminder training will be given 2 weeks later. "Personal Information Form", "Prenatal Attachment Inventory" and "Beck Depression Inventory" will be applied to both groups at the beginning of the study, and postpartum 30-42 weeks. and 60-72. "Maternal Attachment Scale" and "Edinburg Postpartum Depression Scale" will be administered between days.


Recruitment information / eligibility

Status Completed
Enrollment 54
Est. completion date March 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: Being between the ages of 18-35, Being primiparous and having a singleton pregnancy, - No high-risk pregnancy, - Being in the 32nd to 40th week of pregnancy, - Being literate and knowing and understanding Turkish, - Pregnant women who have internet access and knowledge of internet usage. Exclusion Criteria: - ? Presence of chronic disease, - Pregnancy with congenital malformation, - Unwanted pregnancy, - Having attended a pregnancy school, - Women who become pregnant as a result of assisted reproductive technology, - Those with hearing and vision problems, - Having a known serious psychiatric disease diagnosis.

Study Design


Intervention

Behavioral:
Baby massage
After the first measurements are made and the groups are determined; "Personal Information Form", "Perinatal Attachment Inventory" and "Beck Depression Inventory" will be applied to the experimental and control groups. Pregnant women in the experimental group were 32-40 weeks of pregnancy. After baby massage training is given, 30-42 weeks after birth. between days and 60-72. "Maternal Attachment Scale" and "Edinburgh Postpartum Depression Scale" will be applied to the experimental and control groups on the following days. The control group will receive standard care while the experimental group receives training. After the second postpartum data of the pregnant women in the control group are collected, a 30-minute baby massage training will be given by the researcher.

Locations

Country Name City State
Turkey Betül Uncu Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University - Cerrahpasa (IUC)

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary the Maternal Attachment Scale (mother-baby bonding scale) Postpartum ages 30-42 in the Maternal Attachment Scale "Experimental Group". days and 60-72. It will be applied to mothers between days. Postpartum ages 30-42 are in the "Control Group" of the Maternal Attachment Scale. days and 60-72. It will be applied to mothers between days.
Measures maternal feelings and behaviors that show love The lowest score obtained from the scale is 26, the highest score is 104, and a high score indicates high maternal attachment.
3 months
Primary The Edinburgh Postpartum Depression Scale The Edinburgh Postpartum Depression Scale will be used to evaluate and monitor the postpartum depression development levels of the groups. The cut-off score of the scale is 12/13, and women who score above 13 are considered to be at risk for depression. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT06348316 - Early Half Swaddling and Kangaroo Care Practices on Maternal Sleep Quality and Postpartum Depression in Term Babies N/A
Completed NCT05322161 - Yoga in the NICU for Parents Study N/A
Withdrawn NCT03709004 - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression N/A
Completed NCT06305325 - Coparenting Intervention to Prevent Postpartum Depression N/A
Not yet recruiting NCT05055674 - The Effects of Motherly on Postpartum Depression N/A
Enrolling by invitation NCT02323152 - PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK N/A
Not yet recruiting NCT01658098 - Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez N/A
Completed NCT00961402 - The Effect of Exercise on Preventing PostPartum Depression Phase 2
Completed NCT01312883 - Mothers Avoiding Depression Through Empowerment Intervention Trial N/A
Completed NCT00360204 - Improving Health Outcomes for New Mothers and Babies Phase 3
Unknown status NCT00548743 - Translating Research Into Practice for Postpartum Depression N/A
Completed NCT04146025 - Nurtured in Nature N/A
Not yet recruiting NCT06442774 - MamaConecta: Digital Tool for Maternal Mental Health N/A
Recruiting NCT05137925 - Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum N/A
Not yet recruiting NCT05299398 - Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone Phase 1
Completed NCT04925765 - Virtual Reality Biofeedback for Postpartum Anxiety and Depression N/A
Recruiting NCT06053515 - Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication N/A
Completed NCT04037085 - Ketamine to Improve Recovery After Cesarean Delivery - Part 1 Phase 2
Completed NCT05059600 - A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting Phase 4
Recruiting NCT05038085 - Postpartum Depression and Maternal Attachment N/A